EW — Edwards Lifesciences Corp

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 1099800 ·
Last close
$105.43
Market Cap
$60.62B
52W High
$108.00
52W Low
$74.66
ADV30
4,630,470
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,715,500,000 1,346,300,000 517,300,000 307,500,000 14,144,400,000 3,110,800,000 3,182,900,000
Jun 2026 — — — — — — —
Mar 2026 1,648,600,000 1,286,000,000 514,700,000 380,700,000 13,321,200,000 2,445,500,000 2,993,700,000
Dec 2025 1,569,600,000 1,226,600,000 370,300,000 91,200,000 13,697,200,000 2,938,000,000 3,359,600,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,638,700,000
Investing CF
$-975,300,000
Financing CF
$-1,303,500,000
CapEx
$-283,400,000
Dividends Paid
—
Buybacks
$-1,190,000,000
EPS Diluted TTM
$1.77
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$15,170,600,000
Inventory
$1,159,400,000
Receivables
$937,800,000
ST Investments
$1,533,900,000
EBIT TTM
$1,484,500,000
Pretax Income TTM
$1,261,000,000
Interest Exp TTM
—
Analysts
27

Yahoo Snapshot (yfinance, live)

Total Revenue
$6,674,699,776
EBITDA
$2,094,700,032
Free Cash Flow
$1,145,337,472
Enterprise Value
$54,890,700,800
Total Cash
$4,644,700,160
Total Debt
$704,499,968
Shares Out
575,000,000
Trailing EPS
$1.72
Book Value
$18.87
ROE
9.3%
ROA
8.8%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 6,067,600,000 1,636,200,000 1,073,500,000 13,697,200,000 3,359,600,000 10,337,600,000 1,595,200,000
Dec 2024 5,439,500,000 1,480,100,000 4,174,600,000 13,055,300,000 2,992,400,000 9,998,400,000 542,300,000
Dec 2023 5,010,000,000 1,486,200,000 1,402,400,000 9,363,200,000 2,643,800,000 6,650,000,000 895,800,000
Dec 2022 4,464,000,000 1,539,100,000 1,521,900,000 8,292,500,000 2,485,800,000 5,806,700,000 1,218,200,000

TTM Snapshot

Revenues TTM
$6,512,300,000
NetIncome TTM
$1,004,900,000
OpCashFlow TTM
—
Assets (Latest)
$13,867,100,000
Forward EPS
$3.40

Max Pain — expiry 2026-12-18

max pain strike: $90.00 · spot: $105.23 · call oi: 7,071 · put oi: 3,122
Expected Move to 2026-12-18: ±$6.67 (6.34%) — implied range $98.56 – $111.91 · ATM straddle on $105.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
BSX BOSTON SCIENTIFIC CORP $62.37B $43.03 —
BDX BECTON DICKINSON & CO $58.68B $215.42 —
MMM 3M CO $93.28B $180.88 —
GEHC GE HealthCare Technologies Inc. $37.00B $81.84 —
RMD RESMED INC $33.46B $237.85 —

News headlines (Yahoo Finance, 1h cache)

Are Wall Street Analysts Predicting Edwards Lifesciences Stock Will Climb or Sink?
2026-11-16 15:27 · Yahoo
Philips to nominate Dick Boer, Laurence Debroux and Todd Brinton to its Supervisory Board at the 2027 Annual General Meeting of Shareholders (AGM)
2026-11-16 07:30 · Yahoo
Is There Any Reason To Invest In Edwards Lifesciences Stock?
2026-11-14 01:20 · Yahoo
Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment
2026-11-09 16:36 · Yahoo
Edwards Lifesciences Q3 Earnings Call Highlights
2026-11-07 09:18 · Yahoo
Edwards Life (EW) Q3 2026 Earnings Call Transcript
2026-11-05 21:59 · Yahoo
CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?
2026-11-05 18:07 · Yahoo
Edwards Lifesciences Corp (EW) (Q3 2026) Earnings Call Highlights: Broad-Based TAVR and TMTT ...
2026-11-05 17:07 · Yahoo
Edwards bumps up sales forecast on TAVR strength in Q3
2026-11-05 16:02 · Yahoo
Edwards Lifesciences (EW) Trial Data Points To Earlier TAVR Use In Moderate Aortic Stenosis
2026-11-05 13:13 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.